By the integration and analysis of multi‐dimensional genomic data, they identified four clinically relevant subtypes of GBM characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. These are proneural, neural, classical and mesenchymal subtypes. Here, IDH1 is linked to glioblastoma.